Skip to content

Price / book at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
1.1×+0.1×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
0.5×-0.2×
Revvity logo
RevvityRVTY
1.4×-0.3×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
15.7×+7.4×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×

Other financials

Income statement

See full
Revenue$36.4M+20.1%
Gross profit$15.6M+4.9%
Operating income-$41.4M-56.9%
Net income-$17.5M+14.5%
EPS (diluted)-$0.37+30.2%

Balance sheet

See full
Cash & equivalents$36.2M-52.7%
Total debt$35.3M-2.9%
Total equity$282.1M-10.8%
Total assets$366.7M-7.5%

Cash flow

See full
Operating cash flow-$18.1M-30.4%
CapEx$87.0K-93.1%
Free cash flow-$18.2M-20.1%

Valuation

See full
Market cap$203.97M-20.1%
Enterprise value$203.12M+28.6%
P/S1.4×-0.6×

Profitability

See full
Gross margin44.2%-14.3pp
Operating margin-96.9%-1,691pp
Net margin-71.9%-2,019pp
FCF margin-57.2%-220pp

Returns & leverage

See full
Return on equity-34.8%-122pp
Debt / equity0.1×0.0×
Current ratio3.7×-4.6×

Where this comes from

Calculated from Quanterix Corporation’s reported figures.

Based on the most recent quarter.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quanterix Corporation's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quanterix Corporation's price / book?
Quanterix Corporation (QTRX) reported price / book of 0.6× in Q1 2026.
How has Quanterix Corporation's price / book changed year-over-year?
Quanterix Corporation's price / book decreased by 26.6% year-over-year, from 0.8× to 0.6×.
What is the long-term trend for Quanterix Corporation's price / book?
Over 5 years (2020 to 2025), Quanterix Corporation's price / book has grown at a -34.4% compound annual growth rate (CAGR), from 8.3× to 1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.